Latest News in the pharma Industry

Market News

First human trial of monoclonal antibody to prevent malaria opens

First human trial of monoclonal antibody to prevent malaria opens

28 Jan 2020

If proven safe and effective, mAb CIS43LS might be used prophylactically by tourists, medical workers or military personnel who travel to areas where malaria is common.

Read more 
Merck invests in biotech development facility in Switzerland

Merck invests in biotech development facility in Switzerland

27 Jan 2020

€250 million to be invested during the 2019-2022 period in new facility bridging research and manufacturing.

Read more 
AstraZeneca embarks on $1bn zero carbon strategy

AstraZeneca embarks on $1bn zero carbon strategy

24 Jan 2020

The programme will include the launch of next-generation respiratory inhalers, which will use near-zero Global Warming Potential propellants.

Read more 
FDA approves Unidose device for new nasal seizure rescue treatment

FDA approves Unidose device for new nasal seizure rescue treatment

23 Jan 2020

The single-use, ready-to-use, one-step nasal delivery device can deliver a formulation in an emergency situation quickly and easily.

Read more 
Lilly to build new manufacturing facility and create 460 new jobs

Lilly to build new manufacturing facility and create 460 new jobs

22 Jan 2020

The $470 million investment will support a state-of-the-art facility that produces injectable products and delivery devices.

Read more 
Diabetes diagnosis - now a matter of sweat and tears?

Diabetes diagnosis - now a matter of sweat and tears?

21 Jan 2020

No need to draw blood; researchers develop smart technology to diagnose diabetes and treat diabetic retinopathy.

Read more 
Grey Wolf Therapeutics secures funding for cancer therapies development

Grey Wolf Therapeutics secures funding for cancer therapies development

21 Jan 2020

The company targets ERAP antigen presentation pathways with the aim of ‘illuminating’ non-responsive tumours for attack and destruction by the immune system.

Read more 
Forté Pharma strengthens cosmetics range with oral supplement launch

Forté Pharma strengthens cosmetics range with oral supplement launch

20 Jan 2020

Reig Jofre's oral, anti-wrinkle, moisturizing and firming cosmetic expands Forté Pharma's beauty range.

Read more 
Wuxi to acquire Bayer final drug product manufacturing site

Wuxi to acquire Bayer final drug product manufacturing site

17 Jan 2020

First drug product facility in Europe to complement WuXi Biologics’ existing commercial manufacturing capacities.

Read more 
Former Bosch drug packaging division renamed Syntegon

Former Bosch drug packaging division renamed Syntegon

16 Jan 2020

Business to focus on intelligent and sustainable technologies.

Read more 
BioMarin gets go-ahead to start gene therapy clinical trials

BioMarin gets go-ahead to start gene therapy clinical trials

15 Jan 2020

BMN 307 represents a potential third PKU treatment option from BioMarin and its second gene therapy clinical program.

Read more 
French regulator agrees to partial resumption of Tellomak trial patient recruitment

French regulator agrees to partial resumption of Tellomak trial patient recruitment

14 Jan 2020

The French National Agency for Medicines and Health Product Safety (ANSM) has agreed that Innate Pharma’s Tellomak (lacutamab) Phase II trial can resume recruitment of new patients with relapsed/refractory Sézary syndrome and mycosis fungoides (MF) in ...

Read more